Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Prolactin-Producing Pituitary Tumor 1Pituitary ACTH Hypersecretion 1Neoplasm Metastasis 1Metastatic Solid Tumor Cancers 1Lung Neoplasms 1Glioma 1Glioblastoma 1Depression 1Cushing Syndrome 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cancer Caregivers 1

Interventions

Dexamethasone 238Lenalidomide 145daratumumab 123Bortezomib 101pomalidomide 86Calcium Dobesilate 76carfilzomib 74Cyclophosphamide 70Specimen Handling 42isatuximab 40Biopsy 40fludarabine 36belantamab mafodotin 36Magnetic Resonance Spectroscopy 35talquetamab 29dexamethasone acetate 27dexamethasone 21-phosphate 27Melphalan 27auricularum 26iberdomide 25ixazomib 22fludarabine phosphate 22selinexor 21elotuzumab 21Whole-Body Irradiation 14X-Rays 13tocilizumab 12venetoclax 11Mycophenolic Acid 10trametinib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Multiple Myeloma × 4-amino-4'-hydroxylaminodiphenylsulfone × 1 year × Clear all
NCT06126341 2026-02-19

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

Memorial Sloan Kettering Cancer Center

Active not recruiting
49 enrolled
Plasma cell

Multiple Myeloma

NCT04248244 2025-08-11

Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma

Case Comprehensive Cancer Center

Phase NA Completed
20 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡